Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui Zeng

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|January 27, 2022
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50Qiao Liu, Zhen Zhou, Xia Luo, et al.
Plos One|April 13, 2023
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysisLiting Wang, Ye Peng, Shuxia Qin, et al.
Life Sciences|December 14, 2020
Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanismShuangYe Liu, Ya Wang, Shuai Lu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2023
A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screeningTao Peng, Xiaohui Zeng, Yang Li, et al.
Advances in Therapy|May 21, 2021
Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial CancerShuxia Qin, Lidan Yi, Sini Li, et al.
Plos One|May 8, 2020
Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in ChinaSini Li, Liubao Peng, Chongqing Tan, et al.
Advances in Therapy|April 10, 2021
Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese PopulationChongqing Tan, Sini Li, Lidan Yi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 28, 2021
Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4Mulin Feng, Tian Luo, Mo Xian, et al.
Frontiers in Pharmacology|January 7, 2022
First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness AnalysisQiao Liu, Zhen Zhou, Xia Luo, et al.
Journal of Traditional and Complementary Medicine|November 29, 2023
<i>Spatholobus suberectus</i> inhibits lipogenesis and tumorigenesis in triple-negative breast cancer via activation of AMPK-ACC and K-Ras-ERK signaling pathwayXiaohui Zeng, Guowei Gong, Kumar Ganesan, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|January 27, 2022
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50Qiao Liu, Zhen Zhou, Xia Luo, et al.
Plos One|April 13, 2023
First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysisLiting Wang, Ye Peng, Shuxia Qin, et al.
Life Sciences|December 14, 2020
Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanismShuangYe Liu, Ya Wang, Shuai Lu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 5, 2023
A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screeningTao Peng, Xiaohui Zeng, Yang Li, et al.
Advances in Therapy|May 21, 2021
Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial CancerShuxia Qin, Lidan Yi, Sini Li, et al.
Plos One|May 8, 2020
Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in ChinaSini Li, Liubao Peng, Chongqing Tan, et al.
Advances in Therapy|April 10, 2021
Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese PopulationChongqing Tan, Sini Li, Lidan Yi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 28, 2021
Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4Mulin Feng, Tian Luo, Mo Xian, et al.
Frontiers in Pharmacology|January 7, 2022
First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness AnalysisQiao Liu, Zhen Zhou, Xia Luo, et al.
Journal of Traditional and Complementary Medicine|November 29, 2023
<i>Spatholobus suberectus</i> inhibits lipogenesis and tumorigenesis in triple-negative breast cancer via activation of AMPK-ACC and K-Ras-ERK signaling pathwayXiaohui Zeng, Guowei Gong, Kumar Ganesan, et al.
Pageof 13